Longitudinal PET studies have demonstrated pathological changes in vulnerable sporadic AD populations [20–24], but to our knowledge, longitudinal measures of both tau and Aβ PET in conjunction with measures of brain structure and cognitive function have not yet been reported in ADAD. Here, MAPT is linked to Alzheimer disease.